NHMRC Glaucoma Guidelines - ANZGIG

More documents

Recommendations

Info

<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA Chapter 7 – Diagnosis of glaucoma Table 7.3: The relative merits of each form of eye function examination EYE FUNCTION Time Portable Sensitivity (95%CI) Specificity (95%CI) DOR (95%CI) Early diagnosis specificity and sensitivity Frequency doubling technology FDT C-20-1 1, sens all participants (90), early glaucoma excluded (100) Spec all participants (100), early glaucoma excluded (81) FDT C-20-5
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA Chapter 7 – Diagnosis of glaucoma Evidence Statement • Expert/consensus opinion suggests that visual field testing is invaluable to diagnose glaucoma. Point of note A consistent approach to testing visual function at diagnosis, monitoring and follow-up may facilitate assessment of progression across professional settings. Health care providers are advised to utilise equipment that allows comparisons with normal visual fields, and has demonstrated reproducibility to facilitate comparisons with measures taken over time. Health care providers need to interpret product claims with caution when choosing their equipment. Evidence Statement • Expert/consensus opinion suggests that advancing age, visual acuity, patient capability, concurrent ocular conditions, oculo-facial anatomy and spectacle scotomata all impact upon the results and interpretation of visual field testing. Using visual fields to grade glaucoma Burr et al (2007) describes a continuum of glaucoma severity as: • No glaucomatous impairment: Under observation as a glaucoma suspect, however not on medication, and no glaucoma visual field defect in either eye. • Mild glaucoma: On treatment, no binocular visual field loss, unilateral glaucoma visual field defect. • Moderate glaucoma: Up to five missed points (
Page 1:
NHMRC Guidelines for the Screening,
Page 4 and 5:
NHMRC GUIDELINES FOR THE SCREENING,
Page 6 and 7:
Page 8:
Page 12 and 13:
Page 14:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32: NHMRC GUIDELINES FOR THE SCREENING,
Page 38: NHMRC GUIDELINES FOR THE SCREENING,
Page 81: NHMRC GUIDELINES FOR THE SCREENING,
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 172 and 173:
Page 174:
Page 177 and 178:
Page 179 and 180:
Page 181:
show all

NHMRC Glaucoma Guidelines - ANZGIG

Create successful ePaper yourself

Delete template?

Save as template?